Viewing Study NCT01357395


Ignite Creation Date: 2025-12-17 @ 2:48 PM
Ignite Modification Date: 2025-12-23 @ 9:02 PM
Study NCT ID: NCT01357395
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module